HIV-1 Tat C phosphorylates VE-cadherin complex and increases human brain microvascular endothelial cell permeability

BMC Neuroscience

Volumn 15, Issue , 2014, Pages

  Mishra, Ritu ^a   Singh, Sunit K ^a,b  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Adherens junction proteins; Blood brain barrier; Brain microvascular endothelial cells; HIV Neuropathogenesis; HIV 1 Tat C; NOX2; NOX4; ROS

Indexed keywords

BETA CATENIN; FOCAL ADHESION KINASE; FOCAL ADHESION KINASE 2; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TRANSACTIVATOR PROTEIN; VASCULAR ENDOTHELIAL CADHERIN; CADHERIN; CTNNB1 PROTEIN, HUMAN; DIACETYLDICHLOROFLUORESCEIN; FLUORESCEIN DERIVATIVE; FLUORESCENT DYE; LEUKOCYTE ANTIGEN;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN MICROVASCULAR ENDOTHELIAL CELL; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE C; IMMUNOPRECIPITATION; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; UPREGULATION; BRAIN; CAPILLARY PERMEABILITY; CELL CULTURE; ENDOTHELIUM CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMPEDANCE; METABOLISM; MICROVASCULATURE; PHOSPHORYLATION; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULARIZATION; WESTERN BLOTTING;

ANTIGENS, CD; BETA CATENIN; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; BRAIN; CADHERINS; CAPILLARY PERMEABILITY; CELLS, CULTURED; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FLUORESCEINS; FLUORESCENT DYES; HIV-1; HUMANS; IMMUNOPRECIPITATION; MICROVESSELS; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84902919272     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-15-80     Document Type: Article

References (48)

1. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986, 233:1089-1093. 10.1126/science.3016903, 3016903.
2. Kure K, Lyman WD, Weidenheim KM, Dickson DW. Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. Am J Pathol 1990, 136:1085-1092. 1877425, 1693470.
3. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin KM, Krammer PH. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995, 375:497-500. 10.1038/375497a0, 7539892.
4. Strazza M, Pirrone V, Wigdahl B, Nonnemacher MR. Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain Res 2011, 1399:96-115. 3139430, 21641584.
5. Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 2008, 121:2115-2122. 10.1242/jcs.017897, 18565824.
6. Crosby CV, Fleming PA, Argraves WS, Corada M, Zanetta L, Dejana E, Drake CJ. VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood 2005, 105:2771-2776. 10.1182/blood-2004-06-2244, 15604224.
7. Imamura Y, Itoh M, Maeno Y, Tsukita S, Nagafuchi A. Functional domains of alpha-catenin required for the strong state of cadherin-based cell adhesion. J Cell Biol 1999, 144:1311-1322. 10.1083/jcb.144.6.1311, 2150587, 10087272.
8. Daniel JM, Reynolds AB. Tyrosine phosphorylation and cadherin/catenin function. Bioessays 1997, 19:883-891. 10.1002/bies.950191008, 9363682.
9. Harris ES, Nelson WJ. VE-cadherin: at the front, center, and sides of endothelial cell organization and function. Curr Opin Cell Biol 2010, 22:651-658. 10.1016/j.ceb.2010.07.006, 2948582, 20708398.
10. Nawroth R, Poell G, Ranft A, Kloep S, Samulowitz U, Fachinger G, Golding M, Shima DT, Deutsch U, Vestweber D. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J 2002, 21:4885-4895. 10.1093/emboj/cdf497, 126293, 12234928.
11. Neel BG, Gu H, Pao L. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 2003, 28:284-293. 10.1016/S0968-0004(03)00091-4, 12826400.
12. Ukropec JA, Hollinger MK, Salva SM, Woolkalis MJ. SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin. J Biol Chem 2000, 275:5983-5986. 10.1074/jbc.275.8.5983, 10681592.
13. Hatanaka K, Lanahan AA, Murakami M, Simons M. Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2. PLoS One 2012, 7:e37600. 10.1371/journal.pone.0037600, 3358251, 22629427.
14. Dejana E. Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 2004, 5:261-270. 10.1038/nrm1357, 15071551.
15. Potter MD, Barbero S, Cheresh DA. Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state. J Biol Chem 2005, 280:31906-31912. 10.1074/jbc.M505568200, 16027153.
16. Vockel M, Vestweber D. How T cells trigger the dissociation of the endothelial receptor phosphatase VE-PTP from VE-cadherin. Blood 2013, 122:2512-2522. 10.1182/blood-2013-04-499228, 23908467.
17. van Buul JD, Anthony EC, Fernandez-Borja M, Burridge K, Hordijk PL. Proline-rich tyrosine kinase 2 (Pyk2) mediates vascular endothelial-cadherin-based cell-cell adhesion by regulating beta-catenin tyrosine phosphorylation. J Biol Chem 2005, 280:21129-21136. 10.1074/jbc.M500898200, 15778498.
18. Timmerman I, Hoogenboezem M, Bennett AM, Geerts D, Hordijk PL, van Buul JD. The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of beta-catenin phosphorylation. Mol Biol Cell 2012, 23:4212-4225. 10.1091/mbc.E12-01-0038, 3484100, 22956765.
19. Nwariaku FE, Liu Z, Zhu X, Nahari D, Ingle C, Wu RF, Gu Y, Sarosi G, Terada LS. NADPH oxidase mediates vascular endothelial cadherin phosphorylation and endothelial dysfunction. Blood 2004, 104:3214-3220. 10.1182/blood-2004-05-1868, 15271797.
20. Allingham MJ, van Buul JD, Burridge K. ICAM-1-mediated, Src- and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration. J Immunol 2007, 179:4053-4064. 10.4049/jimmunol.179.6.4053, 17785844.
21. Geretti AM. HIV-1 subtypes: epidemiology and significance for HIV management. Curr Opin Infect Dis 2006, 19:1-7. 10.1097/01.qco.0000200293.45532.68, 16374210.
22. Mishra R, Singh SK. HIV-1 Tat C modulates expression of miRNA-101 to suppress VE-cadherin in human brain microvascular endothelial cells. J Neurosci 2013, 33:5992-6000. 10.1523/JNEUROSCI.4796-12.2013, 23554480.
23. Mishra R, Chhatbar C, Singh SK. HIV-1 Tat C-mediated regulation of tumor necrosis factor receptor-associated factor-3 by microRNA 32 in human microglia. J Neuroinflammation 2012, 9:131. 10.1186/1742-2094-9-131, 3418571, 22709905.
24. Poggi A, Carosio R, Fenoglio D, Brenci S, Murdaca G, Setti M, Indiveri F, Scabini S, Ferrero E, Zocchi MR. Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat. Blood 2004, 103:2205-2213. 10.1182/blood-2003-08-2928, 14630801.
25. Re MC, Vignoli M, Furlini G, Gibellini D, Colangeli V, Vitone F, La Placa M. Antibodies against full-length Tat protein and some low-molecular-weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients. J Clin Virol 2001, 21:81-89. 10.1016/S1386-6532(00)00189-X, 11255101.
26. Pieri L, Dominici S, Del Bello B, Maellaro E, Comporti M, Paolicchi A, Pompella A. Redox modulation of protein kinase/phosphatase balance in melanoma cells: the role of endogenous and gamma-glutamyltransferase-dependent H2O2 production. Biochim Biophys Acta 2003, 1621:76-83. 10.1016/S0304-4165(03)00048-5, 12667613.
27. Sun CK, Ng KT, Lim ZX, Cheng Q, Lo CM, Poon RT, Man K, Wong N, Fan ST. Proline-rich tyrosine kinase 2 (Pyk2) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transition. PLoS One 2011, 6:e18878. 10.1371/journal.pone.0018878, 3080371, 21533080.
28. Yuan SY. Protein kinase signaling in the modulation of microvascular permeability. Vascul Pharmacol 2002, 39:213-223. 10.1016/S1537-1891(03)00010-7, 12747961.
29. Johnson TP, Patel K, Johnson KR, Maric D, Calabresi PA, Hasbun R, Nath A. Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein. Proc Natl Acad Sci U S A 2013, 110:13588-13593. 10.1073/pnas.1308673110, 3746932, 23898208.
30. Orsenigo F, Giampietro C, Ferrari A, Corada M, Galaup A, Sigismund S, Ristagno G, Maddaluno L, Koh GY, Franco D, Kurtcuoglu V, Poulikakos D, Baluk P, McDonald D, Grazia Lampugnani M, Dejana E. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun 2012, 3:1208. 3514492, 23169049.
31. Lampugnani MG, Corada M, Andriopoulou P, Esser S, Risau W, Dejana E. Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells. J Cell Sci 1997, 110(Pt 17):2065-2077.
32. Wallez Y, Huber P. Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim Biophys Acta 2008, 1778:794-809. 10.1016/j.bbamem.2007.09.003, 17961505.
33. Angelini DJ, Hyun SW, Grigoryev DN, Garg P, Gong P, Singh IS, Passaniti A, Hasday JD, Goldblum SE. TNF-alpha increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia. Am J Physiol Lung Cell Mol Physiol 2006, 291:L1232-L1245. 10.1152/ajplung.00109.2006, 16891393.
34. Friedl J, Puhlmann M, Bartlett DL, Libutti SK, Turner EN, Gnant MF, Alexander HR. Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF. Blood 2002, 100:1334-1339.
35. Gavard J. Breaking the VE-cadherin bonds. FEBS Lett 2009, 583:1-6. 10.1016/j.febslet.2008.11.032, 19059243.
36. Eum SY, Jaraki D, Bertrand L, Andras IE, Toborek M. Disruption of epithelial barrier by quorum sensing N-3-(oxododecanoyl)-homoserine lactone is mediated by matrix metalloproteinases. Am J Physiol Gastrointest Liver Physiol 2014, 306(11):G992-G1001. 10.1152/ajpgi.00016.2014, 24742991.
37. Huang W, Chen L, Zhang B, Park M, Toborek M. PPAR agonist-mediated protection against HIV Tat-induced cerebrovascular toxicity is enhanced in MMP-9-deficient mice. J Cereb Blood Flow Metab 2014, 34:646-653. 10.1038/jcbfm.2013.240, 24424383.
38. Nakagawa S, Castro V, Toborek M. Infection of human pericytes by HIV-1 disrupts the integrity of the blood-brain barrier. J Cell Mol Med 2012, 16:2950-2957. 10.1111/j.1582-4934.2012.01622.x, 3524391, 22947176.
39. Zhong Y, Zhang B, Eum SY, Toborek M. HIV-1 Tat triggers nuclear localization of ZO-1 via Rho signaling and cAMP response element-binding protein activation. J Neurosci 2012, 32:143-150. 10.1523/JNEUROSCI.4266-11.2012, 3566645, 22219277.
40. Bertocchi C, Vaman Rao M, Zaidel-Bar R. Regulation of adherens junction dynamics by phosphorylation switches. J Signal Transduct 2012, 2012:125295. 3403498, 22848810.
41. Bijli KM, Fazal F, Rahman A. Regulation of Rela/p65 and endothelial cell inflammation by proline-rich tyrosine kinase 2. Am J Respir Cell Mol Biol 2012, 47:660-668. 10.1165/rcmb.2012-0047OC, 3547104, 22842493.
42. Song HY, Ju SM, Seo WY, Goh AR, Lee JK, Bae YS, Choi SY, Park J. Nox2-based NADPH oxidase mediates HIV-1 Tat-induced up-regulation of VCAM-1/ICAM-1 and subsequent monocyte adhesion in human astrocytes. Free Radic Biol Med 2011, 50:576-584. 10.1016/j.freeradbiomed.2010.12.019, 21172429.
43. Yang CM, Lee IT, Hsu RC, Chi PL, Hsiao LD. NADPH oxidase/ROS-dependent PYK2 activation is involved in TNF-alpha-induced matrix metalloproteinase-9 expression in rat heart-derived H9c2 cells. Toxicol Appl Pharmacol 2013, 272:431-442. 10.1016/j.taap.2013.05.036, 23774252.
44. Kundumani-Sridharan V, Dyukova E, Hansen DE, Rao GN. 12/15-Lipoxygenase mediates high-fat diet-induced endothelial tight junction disruption and monocyte transmigration: a new role for 15(S)-hydroxyeicosatetraenoic acid in endothelial cell dysfunction. J Biol Chem 2013, 288:15830-15842. 10.1074/jbc.M113.453290, 3668740, 23589307.
45. Di Paola J. SHPing in different directions in platelet production. Blood 2013, 121:4018-4019. 10.1182/blood-2013-04-493494, 23682031.
46. Vockel M, Vestweber D. How T cells trigger the dissociation of the endothelial receptor phosphatase VE-PTP from VE-cadherin. Blood 2013, 122:2512-2522. 10.1182/blood-2013-04-499228, 23908467.
47. Duan Y, Learoyd J, Meliton AY, Leff AR, Zhu X. Inhibition of Pyk2 blocks lung inflammation and injury in a mouse model of acute lung injury. Respir Res 2012, 13:4. 10.1186/1465-9921-13-4, 3275485, 22257498.
48. Duan Y, Learoyd J, Meliton AY, Clay BS, Leff AR, Zhu X. Inhibition of Pyk2 blocks airway inflammation and hyperresponsiveness in a mouse model of asthma. Am J Respir Cell Mol Biol 2010, 42:491-497. 10.1165/rcmb.2008-0469OC, 2848740, 19520918.